SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-187962
Filing Date
2015-05-14
Accepted
2015-05-14 16:02:46
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d897970d10q.htm 10-Q 435528
2 EXHIBIT 10.21 d897970dex1021.htm EX-10.21 10326
3 EXHIBIT 31.1 d897970dex311.htm EX-31.1 9196
4 EXHIBIT 31.2 d897970dex312.htm EX-31.2 9224
5 EXHIBIT 32.1 d897970dex321.htm EX-32.1 5768
  Complete submission text file 0001193125-15-187962.txt   2460296

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aldx-20150331.xml EX-101.INS 188374
7 XBRL TAXONOMY EXTENSION SCHEMA aldx-20150331.xsd EX-101.SCH 26224
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldx-20150331_cal.xml EX-101.CAL 34910
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldx-20150331_def.xml EX-101.DEF 75074
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldx-20150331_lab.xml EX-101.LAB 227556
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldx-20150331_pre.xml EX-101.PRE 157211
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36332 | Film No.: 15862763
SIC: 2834 Pharmaceutical Preparations